(293) Efficacy Of Alpha Lipoic Acid Supplementation In Sperm Parameters: A Systematic Review And Meta-Analysis Of Randomized Trials

I Zang Pires,M Oberto Da Silva Gobbo,R Yuji Ura Sudo,T Louize Milbradt,N Marquardt Filho,C Teodósio Da Ros
DOI: https://doi.org/10.1093/jsxmed/qdae161.222
2024-12-12
The Journal of Sexual Medicine
Abstract:Introduction Male factors contribute to 30 to 50% of infertility in couples. Treatment options for male infertility are limited, thus antioxidant supplementation for idiopathic male infertility is currently being studied. Alpha lipoic acid (ALA) has a high antioxidant capacity and the potential to penetrate tissues, cells and organelles, including mitochondria, due to its water and lipo solubility properties. The recent inclusion of randomized trials in the literature has required a new systematic review and meta-analysis to evaluate the efficacy of alpha lipoic acid in sperm parameters changes. Objective We aimed to perform a systematic review and meta-analysis of the currently available randomized trials comparing the effects of ALA supplementation versus placebo on sperm function in infertile male patients. Methods Pubmed, Embase, Cochrane Library, and ClinicalTrials.gov databases were searched from inception to June 2024. A random-effects model was employed to compute mean differences and risk ratios for continuous and binary endpoints. Heterogeneity was evaluated through the prediction interval. All statistical analysis was conducted using R software 4.4.1. The certainty of evidence was evaluated with the GRADE approach. Results were reported following the PRISMA statement guidelines. PROSPERO identification: CRD42024564932. Results Five randomized trials comprising 250 patients with a mean age of 28 to 40 years were included in this analysis. Over a mean follow-up time of 3 months, ALA was associated with a reduced proportion of abnormal sperm morphology (MD −0.89; 95% CI −1.48 to −0.29; p = 0.003), increased total motility (MD 13.49; 95% CI 3.52 to 23.46; p = 0.008), and increased sperm progressive motility (MD 12.43; 95% CI 2.89 to 21.97; p = 0.01). Additionally, ALA was associated with a higher pregnancy rate in two individual studies reporting the outcome, however, no significance was found in our pooled analysis (RR 2.28; 95% CI 0.66 to 7.85; p = 0.1). Finally, ALA did not change ejaculation volume (MD 0.14; 95% CI −0.54 to 0.83; p = 0.6), sperm concentration (MD 11.99; 95% CI −0.67 to 24.66; p = 0.06), live sperm (MD 4.42; 95% CI −3.17 to 12.02; p = 0.2), or total antioxidant capacity (MD 0.43; 95% CI −0.02 to 0.87; p = 0.06). No adverse events were reported. Conclusions In this meta-analysis of 5 studies, ALA was associated with a favorable change in sperm function. However, there were no effects on the pregnancy rates. This could be explained by the small sample size and short follow-up time. Therefore, more prospective randomized controlled trials are needed, especially including pregnancy rates and longer follow-up. Disclosure No.
urology & nephrology
What problem does this paper attempt to address?